The cases of adult siblings in Israel, both diagnosed with infantile-onset acquired thrombotic thrombocytopenic purpura (TTP) as children, led to the discovery of a…
Thrombotic thrombocytopenic purpura
Most people with the rare blood disorder immune-mediated thrombotic thrombocytopenic purpura (iTTP) recover well after admission to the intensive care unit (ICU), and treatment with…
A woman with the rare blood disorder congenital thrombotic thrombocytopenic purpura (TTP) safely underwent hip replacement surgery while being treated with Adzynma (ADAMTS13…
A 36-year-old woman in China with congenital thrombotic thrombocytopenic purpura (TTP) successfully delivered a healthy baby after preventive plasma therapy was started early in pregnancy,…
Adults with severe immune thrombotic thrombocytopenic purpura (TTP) who are at a high risk of bleeding may be managed in a hospital’s emergency department…
A young man with unusual blood clots in the spleen was ultimately diagnosed with immune-mediated thrombotic thrombocytopenic purpura (TTP) — also known as acquired…
The number of cases of the blood disorder thrombotic thrombocytopenic purpura (TTP) did not increase during the pandemic, but COVID-19 was linked to more…
Pregnant women with thrombotic thrombocytopenic purpura (TTP) in the U.S. are nearly 20 times more likely to experience an adverse maternal outcome, according to…
An arm of the European Medicines Agency (EMA) is recommending that Wayrilz (rilzabrutinib) be approved to treat adults with immune thrombocytopenia (ITP) who…
Switching from treatment with fresh frozen plasma (FFP) to Adzynma (ADAMTS13, recombinant-krhn) can help people with congenital thrombotic thrombocytopenic purpura (TTP) avoid hospital stays,…
